X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

WHO Asks For Supply Chain Alterations To Fight Contamination

Content Team by Content Team
27th January 2023
in Drug Development, News

The World Health Organization has urged regulators, suppliers, as well as medicine manufacturers to take strict steps against medicines in the supply chain that are contaminated. This is due to the recent instances of over-the-counter cough syrups which had a high level of ethylene glycol and diethylene glycol.

In the past 4 months, there have been cases from at least 7 countries that have been associated, with fatalities touching 300 in three of them. Most happen to be young children who were under the age of 5.

DEG as well as EG happen to be toxic chemicals that are mostly used as industrial solvents and antifreeze agents. Apparently, they should never be found in medicines, as they can be fatal to humans.

Because of this, the medical product alerts by the WHO were quickly sent across to the national health authorities across all 194 WHO member states, thereby requesting-

  • Identifying and removing such contaminated medicines from getting circulated in the market.
  • Enhanced diligence as well as surveillance across the supply chain of regions and the countries that are likely to be affected.
  • Immediately notifying WHO if these substandard components in the product are found out and also inform citizens of dangers and toxic implications of them.

To keep a check on the dissemination of contaminated drugs, the WHO calls on

Drug manufacturers to-

  • Only buy pharmaceutical-grade excipients from qualified suppliers in the supply chain.
  • Get into thorough testing after receiving the supplies.
  • Give out product quality assurance that includes certificates of examination based on the required testing results.
  • Keep a precision-led record of material purchase, its testing and manufacturing as well as distribution in order to help in future traceability in case of incident investigations.

Suppliers as well as distributors of medical products to-

  • Always look for falsification signs and physical medicine conditions, and also other products that they distribute or sell.
  • Only sell or distribute medicines that are authorised by competent authorities.
  • Maintain a proper and precise record of the medicines as well as their distribution.
  • Involve competent personnel to take care of medicines and also give out public advice on the medicines’ right use.

It is well to be noted that the WHO has said that it will continue to engage with member state mechanism as far as falsified and substandard medical products are concerned in putting to practice its mandate to roll out effective partnership in preventing, identifying, and also responding to such products in order to save lives.

Previous Post

Large DNA Sequences Insertion With New Method A Success

Next Post

High Mortality Due To VEXAS Than What Was Previously Thought

Related Posts

Robots and AI in Drug
Articles

Robots and AI in Drug Discovery Are Transforming Medicine

29th May 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Next Post

High Mortality Due To VEXAS Than What Was Previously Thought

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In